Abstract

Interferon (IFN) responses are critical for controlling herpes simplex virus 1 (HSV-1). The importance of neuronal IFN signaling in controlling acute and latent HSV-1 infection remains unclear. Compartmentalized neuron cultures revealed that mature sensory neurons respond to IFNβ at both the axon and cell body through distinct mechanisms, resulting in control of HSV-1. Mice specifically lacking neural IFN signaling succumbed rapidly to HSV-1 corneal infection, demonstrating that IFN responses of the immune system and non-neuronal tissues are insufficient to confer survival following virus challenge. Furthermore, neurovirulence was restored to an HSV strain lacking the IFN-modulating gene, γ34.5, despite its expected attenuation in peripheral tissues. These studies define a crucial role for neuronal IFN signaling for protection against HSV-1 pathogenesis and replication, and they provide a novel framework to enhance our understanding of the interface between host innate immunity and neurotropic pathogens.

Highlights

  • Herpes simplex virus type I (HSV-1) is a highly prevalent neurotropic virus that persists for the lifetime of the host

  • There is no vaccine against HSV, and antiviral drugs can control herpes simplex virus 1 (HSV-1), it persists because it establishes lifelong latent infections in neurons

  • In this study we sought to elucidate the role of neuronal innate immunity in the control of viral infection

Read more

Summary

Introduction

Herpes simplex virus type I (HSV-1) is a highly prevalent neurotropic virus that persists for the lifetime of the host. Reactivation from latency can occur and HSV-1 travels in an anterograde direction down the axon of sensory neurons to the periphery where it undergoes subsequent rounds of lytic replication, enabling viral shedding and host-tohost spread [2]. While HSE can result from primary infection, mostly in newborns, both disease pathologies can result from reactivation of latent HSV which travels to the eye or CNS [4,5]. Nucleoside analogs such as acyclovir (ACV) reduce HSE mortality significantly, but survivors are often left with long-term neurological sequelae, and ACV cannot eliminate the latent virus reservoir [5]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.